711 (Mesalamine Delayed-Release 1.2 g)

Pill with imprint 711 is Brown, Elliptical / Oval and has been identified as Mesalamine Delayed-Release 1.2 g. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Mesalamine is used in the treatment of crohn's disease, maintenance; inflammatory bowel disease; ulcerative colitis, maintenance; ulcerative colitis; ulcerative proctitis and belongs to the drug class 5-aminosalicylates. Excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 1.2 g is not a controlled substance under the Controlled Substances Act (CSA).

Images for 711

Save up to 80% off prescription medications

Click here for your free Discount Card

Mesalamine Delayed-Release

Imprint

711

Strength

1.2 g

Color

Brown

Size

10.00 mm

Shape

Elliptical / Oval

Availability

Prescription only

Drug Class

5-aminosalicylates

Pregnancy Category

B - No proven risk in humans - excluding Asacol and Asacol HD, C - Risk cannot be ruled out - Asacol and Asacol HD

CSA Schedule

Not a controlled drug

Labeler / Supplier

Zydus Pharmaceuticals (USA) Inc.

National Drug Code (NDC)

68382-0711

Inactive Ingredients

carboxymethylcellulose sodium, microcrystalline cellulose, ferric oxide red, ferric oxide yellow, hypromelloses, magnesium stearate, methacrylic acid, silicon dioxide, sodium starch glycolate type A potato, magnesium silicate, titanium dioxide, triethyl citrate

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Related Images for "711"

Glucophage

Singulair

Rynatan

View more

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer